Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma receiving medium-to-high dose inhaled corticosteroids.
Epistemonikos ID: 54f1d4a15e5500bcb0aebc258bb0d270a9f2b6fa
First added on: Apr 18, 2025